Equity research analysts have provided views on where they believe HealthSouth Corporation (NYSE:HLS) will be trading in the future. According to Thomson Reuters, analysts are projecting a consensus target price of $45.22 on company shares. Sell-side analysts tap into their vast knowledge of the company to help gauge future stock movement. Because of the various techniques used, analysts may come up with very different stock target estimates.
After a look at recent stock performance, shares have traded $0.59 off of the 50-day moving average of $40.19 and $0.34 off of the 200-day moving average of $40.44. Shares have been recorded at -5.99% separated from the 52-week high of 43.38 and +34.77% away from the 52-week low of 30.26. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.
Street analysts have the ability to employ multiple metrics to help calculate target price estimates. A common metric is a company’s P/E Ratio. This calculation is derived by dividing the current share price by the projected earnings per share. HealthSouth Corporation Common presently has a P/E Ratio of 17.00. Investors may also monitor a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A PEG Ratio under one may indicate that the company is undervalued. If a company has a PEG Ratio above one, it may represent that the company is overvalued. A PEG Ratio near one might be seen as fair value. The company has a current PEG Ratio of 1.20.